Supplementary Fig. S4 from Functionally Characterizing the Renal Cell Carcinoma Tumor-Immune Microenvironment via Patient-Derived Ex Vivo Models
Abstract
Patient-derived ex vivo model validation and anti-CD3/CD28/CD2 responses (related to Fig. 4).
Fields of Study & Subjects
Cancer Immunotherapy and Biomarkers
Renal cell carcinoma treatment
Immunotherapy and Immune Responses
Publication details
- Publication date
- 26 February 2026
- Language
- EN